Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers

Journal of Clinical Oncology

Volumn 18, Issue 18, 2000, Pages 3221-3229

  Kersting, M ^a   Friedl, C ^a   Kraus, A ^a   Behn, M ^a   Pankow, W ^a   Schuermann, M ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BRONCHOSCOPY; EARLY DIAGNOSIS; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; LUNG CANCER; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; METHYLATION; ONCOGENE K RAS; PRIORITY JOURNAL; PROMOTER REGION; SMOKING; SMOKING HABIT; SPUTUM ANALYSIS; TUMOR BIOPSY;

EID: 0034666334     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.18.3221     Document Type: Article

References (51)

1. Cancer statistics
2. Outcome of 51 patients with roentgenographically occult lung cancer detected by sputum cytologic testing: A community hospital program
3. The National Cancer Institute Cooperative Early Lung Cancer Detection Program: Results of the initial screen (prevalence) - Early lung cancer detection: Introduction
4. Sputum cytopathology: Use and potential in monitoring the workplace environment by screening for biological effects of exposure
5. Progress in understanding the molecular pathogenesis of human lung cancer
6. Molecular abnormalities in lung cancer
7. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based 'enriched PCR' technique
8. Molecular markers for the diagnosis and prognosis of lung cancer
9. Molecular genetic changes found in human lung cancer and its precursor lesions
10. Overview of genetic and molecular events in the pathogenesis of lung cancer
11. The molecular biology of lung cancer pathogenesis
12. Clinical significance of ras oncogene activation in human lung cancer
13. K-ras mutations in human adenocarcinoma of the lung: Association with smoking and occupational exposure to asbestos
14. K-ras gene point mutation: A stable tumor marker in non-small cell lung carcinoma
15. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer
16. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma
17. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines
18. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung
19. The ras oncogenes in human lung cancer
20. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer: Lung Cancer Study Group
21. p53 mutations and histological type of invasive breast carcinoma
22. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern
23. Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancer
24. p53 Accumulation and proliferating-cell nuclear antigen expression in human lung cancer
25. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
26. K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas
27. Human non-small cell lung cancer: p53 Protein accumulation is an early event and persists during metastatic progression
28. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung
29. p53 Expression in normal and dysplastic bronchial epithelium and in lung carcinomas
30. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
31. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer
32. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis
33. Multiple mechanisms of p16(INK4A) inactivation in non-small cell lung cancer cell lines
34. Distinct patterns of inactivation of p15(INK4B) and p16(INK4A) characterize the major types of hematological malignancies
35. Revisions in the International System for Staging Lung Cancer
36. Comparison of methods for extracting DNA from formalin-fixed paraffin sections for nonisotopic PCR
37. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
38. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands
39. Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1
40. Whole genome amplification from a single cell: Implications for genetic analysis
41. p16(INK4a) promoter is hypermethylated at a high frequency in esophageal adenocarcinomas
42. p53 And disease progression in patients with non-small cell lung cancer
43. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: Relationship with p53 and MDM2 protein expression
44. Widely dispersed p53 mutation in respiratory epithelium: A novel mechanism for field carcinogenesis
45. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis
46. Detection of K-ras gene mutations in non-neoplastic lung tissue and lung cancers
47. Detection of K-ras mutations of bronchoalveolar lavage fluid cells aids the diagnosis of lung cancer in small pulmonary lesions
48. High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer
49. K-ras mutation in sputum of patients with or without lung cancer
50. Evolution of neoplastic cell lineages in Barrett oesophagus
51. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients